Introduction
Bacillus strains have noteworthy features -they produce various bioactive materials to control crop diseases and form endospores that endure harsh conditions. However, wild-type Bacillus strains usually display low levels of antibiotic activity in the field compared with chemical pesticides, which reduces their potential as ecofriendly biocontrol agents. Therefore, it is desirable to engineer Bacillus strains to overproduce antibiotic metabolites. Furthermore, engineering Bacillus strains for agricultural applications should not leave foreign DNA in the genome before release into the natural ecosystem.
Traditionally, the random mutagenesis approach was widely used for strain improvement to overproduce antibiotic metabolites. A 1.6-fold increased level of bacitracin was reported in B. licheniformis GP-35 with ultraviolet radiation treatment, and additional N-methyl-N'-nitro-Nnitrosoguanidine (MNNG) treatment yielded a 2.2-fold increase in bacitracin compared with the wild type [1] . In addition to Bacillus sp., random mutagenesis was also reported as an appropriate approach to induce the secretion of antibacterial compounds in Aspergillus oryzae [2]. However, random mutagenesis allows for the accumulation of undesired mutations other than the target of interest, while requiring laborious screening steps. Therefore, rational engineering for the production of natural products is urgently required [3] .
In Bacillus sp., antibiotic synthesis is regulated by transcriptional regulators such as DegQ, ScoC, Spo0A, ComA, . Among them, DegU is a response regulator of the DegS-DegU two-component system, and both unphosphorylated and phosphorylated DegU proteins can act as transcriptional regulators [7, 8] . It has been reported that the deletion of degU decreases the expression of antibiotic biosynthetic genes, such as pksC in B. subtilis and bmy in B. amyloliquefaciens [6, 9] . DegU32, which contains leucine as the 12 t h amino acid residue instead of histidine in the degU gene, is known to be maintained in its phosphorylated form longer than the wild type and has Bacillus strains produce various types of antibiotics, and random mutagenesis has traditionally been used to overproduce these natural metabolites. However, this method leads to the accumulation of unwanted mutations in the genome. Here, we rationally designed a single nucleotide substitution in the degU gene to generate a B. subtilis strain displaying increased plipastatin production in a foreign DNA-free manner. The mutant strain (BS1028u) showed improved antifungal activity against Pythium ultimum. Notably, pps operon deletion in BS1028u resulted in complete loss of antifungal activity, suggesting that the antifungal activity strongly depends on the expression of the pps operon. Quantitative real-time PCR and lacZ assays showed that the point mutation resulted in 2-fold increased pps operon expression, which caused the increase in antifungal activity. Likewise, commercial Bacillus strains can be improved to display higher antifungal activity by rationally designed simple modifications of their genome, rendering them more efficient biocontrol agents.
Keywords: Bacillus subtilis, genome engineering, degU, antibiotics, plipastatin been reported to induce higher expression of extracellular enzymes [10, 11] . These reports suggest that the degU gene can be a suitable target for rational engineering to increase antibiotic production in Bacillus sp.
In this study, we modified the synthetic gene circuit method [12] to construct a single base substitution in B. subtilis KCTC1028 without foreign DNA insertions into the chromosome. The results reveal that a mutation in DegU increased the expression level of a plipastatin biosynthetic gene cluster and the mutant strain showed increased antifungal activity, suggesting that simple modification of the genome could enable wild-type Bacillus strains to work as more efficient biocontrol agents.
Materials and Methods

Plasmid Construction
Primers used in this study are shown in Table 1 . Two degUm fragments, a P x y l -lacI-neo fragment, and a linearized vector YEp352 [13] were used to clone YuINu by using a yeast in vivo recombination system. Primers F2 and R1 contain a single nucleotide change (A to T) at the 35 t h nucleotide in the degU structural gene. The first degUm fragment was obtained by PCR using primer sets F3/R1 and F2/R3, followed by fusion PCR. The second degUm fragment was obtained by PCR using primer sets F5/R1 and F2/R5, also followed by fusion PCR. The B. subtilis KCTC1028 (BS1028) chromosome was used as the template to amplify the two degUm fragments. Using primers F4 and R4, the P x y l -lacI-neo fragment was PCR amplified from an integration vector, pUlac-neo [12] . XbaI-and BamHI-digested YEp352 and all three PCR-amplified fragments were introduced into Saccharomyces cerevisiae Y2805 [14] using the Yeastmaker Yeast Transformation System 2 (Clontech, USA) following the manufacturer's instructions. The two degUm fragments and the P x y l -lacI-neo fragment were appropriately assembled along with the linearized YEp352 plasmid to construct the plasmid YuINu. Plasmid construction was confirmed by PCR and sequencing.
The pps promoter was amplified from BS1028 chromosome using primers PppsA-f/PppsA-r. The PCR product was then digested with EcoRI and BamHI and cloned into linearized pDG1661 [15] to produce pD82-Ppps. Promoter construction was further confirmed with sequence analysis.
Construction of the degUm Mutant
The synthetic gene circuit method [12] was used to construct the degUm mutant in BS1028. Two degUm fragments and P x y l -lacIneo were amplified from the YuINu plasmid using PCR with primers F3/R5, and introduced into BS1028 containing the helper 
